NCT05808140View on ClinicalTrials.gov

Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Disc Herniation
Interventions
DRUG

Indocyanine Green

Preoperatively, a single dose of intravenous indocyanine green is administered

DEVICE

Fluorescence imaging

Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively

Trial Locations (1)

430062

Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER